Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semaglutide Treatment for Alcohol Use Disorder After Metabolic and Bariatric Surgery: A Pilot Randomized Controlled Trial

NCT07223983 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT07223983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07223983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semaglutide Treatment for Alcohol Use Disorder After Metabolic and Bariatric Surgery: A Pilot Randomized Controlled Trial
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 26, 2026
Completion date
February 28, 2027
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, bariatric surgery patients, weight loss